Related Experiment Video
Updated: Aug 11, 2026
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Molecular prognostic markers in ovarian cancer: toward patient-tailored therapy
A P G Crijns1, E W Duiker, S de Jong
1Department of Gynecological Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Abstract:
In ovarian cancer the ceiling seems to be reached with chemotherapeutic drugs. Therefore a paradigm shift is needed. Instead of treating all patients according to standard guidelines, individualized molecular targeted treatment should be aimed for. This means that molecular profiles of the distinct ovarian cancer subtypes should be established. Until recently, most studies trying to identify molecular targets were single-marker studies. The prognostic role of key components of apoptotic and prosurvival pathways such as p53, EGFR, and HER2 has been extensively studied because resistance to chemotherapy is often caused by failure of tumor cells to go into apoptosis. However, it is more than likely that different ovarian cancer subtypes with extensive molecular heterogeneity exist. Therefore, exploration of the potential of specific tumor-targeted therapy, based on expression of a prognostic tumor profile, may be of interest. Recently, new profiling techniques, such as DNA and protein microarrays, have enabled high-throughput screening of tumors. In this review an overview of the current status of prognostic marker and molecular targeting research in ovarian cancer, including microarray studies, is presented.
Insights
Chemotherapy resistance in ovarian cancer necessitates a shift towards individualized treatments. Molecular profiling of ovarian cancer subtypes can identify targets for personalized, tumor-specific therapies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Ovarian cancer treatment often reaches a plateau with conventional chemotherapy.
- Chemotherapy resistance is frequently linked to the dysregulation of apoptotic and prosurvival pathways.
- Existing research has primarily focused on single molecular markers.
Purpose of the Study:
- To review the current status of prognostic marker and molecular targeting research in ovarian cancer.
- To highlight the need for a paradigm shift towards individualized, molecularly targeted therapies.
- To discuss the potential of high-throughput profiling techniques in identifying new therapeutic targets.
Main Methods:
- Review of existing literature on prognostic markers in ovarian cancer.
- Analysis of studies investigating apoptotic and prosurvival pathways (e.g., p53, EGFR, HER2).
- Inclusion of recent microarray studies for high-throughput tumor screening.
Main Results:
- Single-marker studies have extensively explored prognostic roles of key pathway components.
- Molecular heterogeneity among ovarian cancer subtypes is increasingly recognized.
- Microarray techniques enable comprehensive screening for prognostic tumor profiles.
Conclusions:
- Individualized molecular targeted treatment is crucial for overcoming chemotherapy resistance in ovarian cancer.
- Establishing molecular profiles of distinct ovarian cancer subtypes is essential for developing targeted therapies.
- Exploration of prognostic tumor profiles using advanced techniques holds promise for novel therapeutic strategies.
More Related Videos
09:40Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
08:26Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages
Published on: February 23, 2024
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...